← Leaderboards
Matteo Ligorio
Ut Southwestern Medical Center
$2,328,586
Attributed
$2,328,586
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $493.7K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,328,586 · 1
By mechanism
R37$2,328,586 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Daniel D Billadeau$13,701,310
- Diego H Castrillon$18,503,509
- Angelique Wright Whitehurst$6,833,234
- Ivan Pedrosa$7,238,451
- Guanghua Xiao$9,069,817
Others in their field
Other Emerging Leaders on “Human Tissue”
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$55,356,482
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$32,915,493
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,477,162
- Hemali Phatnani · New York University School Of Medicine$22,551,091
Research focus
Human TissueArchitectureAdultBehaviorBiologicalBiological MarkersAftercareCellsChemoresistanceChemotherapyClinical TrialsColorCore BiopsyCrispr ScreenCancer CellDisease ProgressionEngineeringEvolutionExtracellular MatrixFibronectinsGenome-WideGlandHomeostasisImaging Techniques
Grant awards (5)
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer$469,327
R37 · FY2025 · CA · contact PI
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer$445,861
R37 · FY2024 · CA · contact PI
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer$459,941
R37 · FY2023 · CA · contact PI
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer$459,799
R37 · FY2022 · CA · contact PI
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer$493,658
R37 · FY2021 · CA · contact PI